WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 71 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,874,046 | +262.8% | 1,587,724 | +863.5% | 0.00% | – |
| Q1 2024 | $1,067,852 | +283.0% | 164,792 | +128.2% | 0.00% | – |
| Q4 2023 | $278,800 | +68.9% | 72,228 | -6.3% | 0.00% | – |
| Q3 2023 | $165,022 | -26.9% | 77,113 | +4.2% | 0.00% | – |
| Q2 2023 | $225,642 | +122.6% | 73,981 | +89.7% | 0.00% | – |
| Q1 2023 | $101,385 | +28.3% | 38,994 | +1.2% | 0.00% | – |
| Q4 2022 | $79,003 | -88.2% | 38,538 | -74.0% | 0.00% | – |
| Q3 2022 | $668,000 | -11.2% | 148,009 | -19.5% | 0.00% | – |
| Q2 2022 | $752,000 | -86.7% | 183,957 | -85.7% | 0.00% | – |
| Q1 2022 | $5,647,000 | -62.8% | 1,283,545 | +0.6% | 0.00% | – |
| Q4 2021 | $15,200,000 | +139.4% | 1,276,208 | +245.0% | 0.00% | – |
| Q3 2021 | $6,349,000 | -0.5% | 369,961 | +1.1% | 0.00% | – |
| Q2 2021 | $6,381,000 | – | 365,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,437,409 | 23.87% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $10,453,380 | 5.74% |
| MPM BioImpact LLC | 2,388,011 | $5,826,747 | 0.90% |
| PFM Health Sciences, LP | 3,241,074 | $7,908,221 | 0.39% |
| Eagle Health Investments LP | 700,000 | $1,708,000 | 0.30% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,529,416 | 0.21% |
| RA Capital Management | 6,144,881 | $14,993,510 | 0.20% |
| Rubric Capital Management LP | 1,333,893 | $3,254,699 | 0.08% |
| Murchinson Ltd. | 62,500 | $152,500 | 0.02% |
| Alpine Global Management, LLC | 37,551 | $91,624 | 0.02% |